S

Sera Prognostics

95 employees

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Preterm Birth
preemie
Obstetrics
Pregnancy
Health Care
premature birth
Prematurity
Proteomics
Medical
Maternal Fetal Medicine
Hospital

Date founded

2008

Funding rounds raised

Total raised

$100M

from 20 investors over 20 rounds

S

Sera Prognostics raised $100M on April 28, 2021

Investors: aMoon Fund, Parian Global Management LP, Elevance Health, Blue Ox Healthcare Partners and Vivo Capital

S

Sera Prognostics raised $36M on November 13, 2019

Investors: Blue Ox Healthcare Partners

S

Sera Prognostics raised $40M on January 10, 2017

Investors: Catalyst Health Ventures and Labcorp

S

Sera Prognostics raised $20M on January 7, 2015

Investors: UpStart Life Sciences Capital, Domain Associates and InterWest Partners

S

Sera Prognostics raised $5M on November 18, 2014

Investors: UpStart Life Sciences Capital, Catalyst Health Ventures and Domain Associates

S

Sera Prognostics raised $19M on November 15, 2011

Investors: Domain Associates, InterWest Partners, Osage University Partners (OUP) and Catalyst Health Ventures

S

Sera Prognostics raised $1.4M on January 4, 2011

Investors: Excelestar Ventures LLC and Catalyst Health Ventures

FAQ